Papers associated with head (and grin2d)

Limit to papers also referencing gene:
Show all head papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups., Perszyk R., Elife. May 24, 2018; 7
	A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons., Kostakis E., J Neurochem. November 1, 2011; 119 (3): 486-96.
	Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids., Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.
	Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket., Kinarsky L., J Pharmacol Exp Ther. June 1, 2005; 313 (3): 1066-74.
	Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists., Morley RM., J Med Chem. April 7, 2005; 48 (7): 2627-37.
	The effect of competitive antagonist chain length on NMDA receptor subunit selectivity., Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.
	The micromolar zinc-binding domain on the NMDA receptor subunit NR2B., Rachline J., J Neurosci. January 12, 2005; 25 (2): 308-17.
	Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus., Lozovaya NA., J Physiol. July 15, 2004; 558 (Pt 2): 451-63.
	Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors., Chen PE., J Physiol. July 1, 2004; 558 (Pt 1): 45-58.
	Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid., Feng B., Br J Pharmacol. February 1, 2004; 141 (3): 508-16.
	Oxygen sensitivity of NMDA receptors: relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons., Bickler PE., Neuroscience. January 1, 2003; 118 (1): 25-35.
	N-Methyl-D-aspartate receptor subtype-selectivity of homoquinolinate: an electrophysiological and radioligand binding study using both native and recombinant receptors., Grimwood S., J Neurochem. August 1, 2002; 82 (4): 794-800.
	Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids., Malayev A., Br J Pharmacol. February 1, 2002; 135 (4): 901-9.
	NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A., Goebel DJ., Brain Res Mol Brain Res. June 8, 1999; 69 (2): 164-70.
	Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes., Buller AL., Eur J Pharmacol. February 5, 1997; 320 (1): 87-94.
	Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol., Ilyin VI., Mol Pharmacol. December 1, 1996; 50 (6): 1541-50.
	The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition., Buller AL., J Neurosci. September 1, 1994; 14 (9): 5471-84.

???pagination.result.page??? 1